Białecki, Tomasz Rybotycki, Tomasz Tworzydło, Jakub Bednorz, Adam
Published in
Frontiers in Physics
We analyze the results of the test of π/2 qubit rotations on a public quantum computer provided by IBM. We measure a single qubit rotated by π/2 about a random axis, and we accumulate vast statistics of the results. The test performed on different devices shows systematic deviations from the theoretical predictions, which appear at level 10–3. Some...
Ellison, Gary L Helzlsouer, Kathy J Rosenfield, Sonia M Kim, Yun Ashare, Rebecca L Blaes, Anne H Cullen, Jennifer Doran, Neal Ebbert, Jon O Egan, Kathleen M
...
BackgroundThe legal climate for cannabis use has dramatically changed with an increasing number of states passing legislation legalizing access for medical and recreational use. Among cancer patients, cannabis is often used to ameliorate adverse effects of cancer treatment. Data are limited on the extent and type of use among cancer patients during...
Schonfeld, Sara J Valcarcel, Bryan Meyer, Christa L Shaw, Bronwen E Phelan, Rachel Rizzo, J Douglas Brunson, Ann Cooley, Julianne JP Abrahão, Renata Wun, Ted
...
AbstractCompared with the general population, hematopoietic cell transplantation (HCT) survivors are at elevated risk for developing solid subsequent neoplasms (SNs). The Center for International Blood and Marrow Transplant Research (CIBMTR) is a key resource for quantifying solid SN incidence following HCT, but the completeness of SN ascertainment...
Lanier, Lewis L
The first descriptions of "non-specific" killing of tumor cells by lymphocytes were reported in 1973, and subsequently, the mediators of the activity were named "natural killer" (NK) cells by Rolf Kiessling and colleagues at the Karolinska Institute in 1975. The activity was detected in mice, rats, and humans that had no prior exposure to the tumor...
Ashcroft, Margaret Thomas, Luke Stephen, Jenna
CHCHD4 (MIA40) is central to the functions of the mitochondrial disulfide relay system (DRS). CHCHD4 is essential and evolutionarily conserved. Previously, we have shown CHCHD4 to be a critical regulator of tumour cell growth. Here, we use integrated analysis of our genome-wide CRISPR/Cas9 and SILAC proteomic screening data to delineate mechanisms ...
Vear, Natalie K Moon, Yubin Mielke, Gregore I Skinner, Tina L Coombes, Jeff S McCarthy, Alexandra L Abbott, Claudia R Bailey, Tom G
Published in
Journal of cancer survivorship : research and practice
Cancer treatments exert vascular toxic effects that can lead to the development of cardiovascular disease. Exercise training has the potential to prevent or reduce cancer treatment-induced damage to vascular structure and function. This systematic review with meta-analyses aimed to determine the isolated effects of exercise training on vascular out...
Lott, Paul C Chiu, Katherine Quino, Juanita Elizabeth Vang, April Pangia Lloyd, Michael W Srivastava, Anuj Chuang, Jeffrey H Consortium, for the PDXNet Carvajal-Carmona, Luis G
Precision medicine holds great promise for improving cancer outcomes. Yet, there are large inequities in the demographics of patients from whom genomic data and models, including patient-derived xenografts (PDX), are developed and for whom treatments are optimized. In this study, we developed a genetic ancestry pipeline for the Cancer Genomics Clou...
Shi, Yu
Cancer poses a significant global health challenge. With an estimated 20 million new cases diagnosed worldwide in 2022 and 9.7 million fatalities attributable to the disease, the economic burden of cancer is immense. It impacts healthcare systems and imposes substantial costs for its care on patients and their families. Despite advancements in earl...
Sterpin, E.; 106731; Widesott, L.; Poels, K.; Hoogeman, M.; Korevaar, E.W.; Lowe, M.; Molinelli, S.; Fracchiolla, F.;
Compared to conventional radiotherapy using X-rays, proton therapy, in principle, allows better conformity of the dose distribution to target volumes, at the cost of greater sensitivity to physical, anatomical, and positioning uncertainties. Robust planning, both in terms of plan optimization and evaluation, has gained high visibility in publicatio...
Leiva, Orly Yang, Eric H Rosovsky, Rachel P Alviar, Carlos Bangalore, Sripal
BackgroundCancer patients are at risk of pulmonary embolism (PE). Catheter-based therapies (CBT) are novel reperfusion options for PE though data in patients with cancer is lacking.Study design and methodsPatients with intermediate- or high-risk PE were identified using the National Readmission Database (NRD) from 2017 to 2020. Primary outcome were...